Cargando…

Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma

British Journal of Cancer (2002) 87, 689–689. doi:10.1038/sj.bjc.6600504 www.bjcancer.com © 2002 Cancer Research UK Correction to: British Journal of Cancer (2002) 86, 1270. doi:10.1038/sj/bjc/6600232

Detalles Bibliográficos
Autores principales:	Rohloff, J, Zinke, J, Schoppmeyer, K, Tannapfel, A, Witzigmann, H, Mössner, J, Wittekind, C, Caca, K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364236/ http://dx.doi.org/10.1038/sj.bjc.6600504

Ejemplares similares

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
por: Rohloff, J, et al.
Publicado: (2002)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo
por: Xiong, Zhen, et al.
Publicado: (2022)

Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
por: Halm, U, et al.
Publicado: (2000)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2010)

Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2019)

Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer
por: Song, He, et al.
Publicado: (2022)

Corrigendum to “High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer”
por: Yang, Long, et al.
Publicado: (2019)

Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion
por: Lee, J Y, et al.
Publicado: (2014)

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy
por: Maeda, J, et al.
Publicado: (2008)

Prognostic significance of heparanase expression in primary and metastatic breast carcinoma
por: Vornicova, Olga, et al.
Publicado: (2017)

The prognostic significance of heparanase expression in metastatic melanoma
por: Vornicova, Olga, et al.
Publicado: (2016)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

DRAM-3 modulates autophagy and promotes cell survival in the absence of glucose
por: Mrschtik, M, et al.
Publicado: (2017)

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer
por: Ng, K, et al.
Publicado: (2010)

No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy
por: Walker, Alexandra K, et al.
Publicado: (2018)

Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer
por: Michalaki, V, et al.
Publicado: (2004)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Has the survival of patients with glioblastoma changed over the years?
por: deSouza, R M, et al.
Publicado: (2016)

Corrigendum to “Regional Anesthesia for Postoperative Pain Control”
por: Eroglu, Ahmet, et al.
Publicado: (2015)

Corrigendum: Lymphangiographic Interventions to Manage Postoperative Chylothorax
por: Jeong, Hyuncheol, et al.
Publicado: (2020)

The Heparanase Regulatory Network in Health and Disease
por: Mayfosh, Alyce J., et al.
Publicado: (2021)

Heparanase and Autoimmune Diabetes
por: Simeonovic, Charmaine J., et al.
Publicado: (2013)

Multiple simultaneous gastric carcinomas.
por: Wittekind, C., et al.
Publicado: (1997)

Magnetic field exposure and long-term survival among children with leukaemia
por: Foliart, D E, et al.
Publicado: (2006)

Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
por: Park, Y, et al.
Publicado: (2009)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: Matthews, LH McCormick, et al.
Publicado: (2015)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
por: O'Brien, P M, et al.
Publicado: (2008)

Corrigendum: Health monitoring and health indicators in Europe
por: Fehr, Angela, et al.
Publicado: (2018)

Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?
por: Forbes, L J L, et al.
Publicado: (2014)

Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2020)

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum]
Publicado: (2021)

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum]
Publicado: (2021)

Personality traits and cancer survival: a Danish cohort study
por: Nakaya, N, et al.
Publicado: (2006)

Corrigendum to “4-Phenylbutyric Acid Attenuates Pancreatic Beta-Cell Injury in Rats with Experimental Severe Acute Pancreatitis”
por: Hong, Yu-pu, et al.
Publicado: (2018)

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
por: White, N M A, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gn9oi1haknakcisl0jqgo4t02a